This account presents previous and recent mechanistic studies of the Heck reactions reported by the authors whose attention has been focused on a problem of the coupling of catalyst transformations within and without the catalytic cycle. Based on the understanding of the interaction mechanism between these processes a development of new methods of Heck chemistry became conceivable. In particular, such a rational approach allowed an elaboration of the ligand-free systems, which are effective not only in the reaction with non-activated aryl bromides but also with nonactivated aryl chlorides. 1 Introduction 2 Main Catalytic Cycle 2.1 Pd(0)/Pd(II) Catalytic Cycle 2.2 Rate-Limiting Step of the Main Catalytic Cycle in the Heck Reaction with Aryl Iodides 3 Reactions without the Main Catalytic Cycle of the Heck Reaction 3.1 Reduction of Palladium 3.2 Oxidation of Palladium 3.3 Agglomeration of Palladium 3.4 Dissolution of Palladium 3.5 Dissolution of Palladium as a Rate-Limiting Step of the Heck Reaction with Aryl Bromides 4 Coupling Effects of the Catalyst Reactions within and without the Main Catalytic Cycle 4.1 Reaction with Aryl Iodides 4.2 Reaction with Aryl Bromides and Aryl Chlorides 4.3 Reaction with the Heterogeneous Catalyst Precursors 5 Conclusions and Outlook
Using of reducing agents for arylation of alkenes has been found to increase the activity of the catalytic system and allow to avoid the use of traditional tertiary amines as bases in the Heck reaction.
ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.